ArticleEuropean journal of clinical pharmacology2026

Cutaneous melanoma and JAK inhibitors: a disproportionality analysis in EudraVigilance.

Rita Nogueiras-Álvarez et al.PubMed ↗Publisher ↗

No numbers read from the abstract.